Association between immune check point inhibitors and digestive system inflammatory adverse reactions: evidence from pharmacovigilance analysis and systematic review
Ya Zou(Chengdu Second People's Hospital), Li Chen(Harvard University), Shibo Lin(Jiangsu Province Hospital), Qinchuan Li(Zhejiang Sci-Tech University), Hongju Wang(Zhejiang International Studies University), Wei Hua(Huashan Hospital), Yan Zhou(National Institute of Metrology), Shihao Yan(Edith Cowan University), Lu Zhou(Chengdu Second People's Hospital), Chun Liu(Chengdu Second People's Hospital), Xirui Guo(Chengdu Second People's Hospital), Yun Lu(Chengdu Second People's Hospital)
Cited by 2
Related Papers
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
|Nature Medicine|2009|666
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555
Low Probability of Detection Communication: Opportunities and Challenges
|IEEE Wireless Communications|2019|363